He speaks of drugs having levelled the playing field and ironically that may be true: by accusing others in his sport of doping, he has unfortunately brought those cyclists who do not use drugs - some of whom he may have denied worthy victory in the Tour de France - down to his level.
There is a growing body of evidence that the use of anabolic steroids in young men can lead to testicular cancer, casting suspicion that Lance Armstrong's doping may even have led to his disease.
Although the suspicions have not been proven, or for that matter discussed by Armstrong, there is sufficient cause to believe he had been using drugs from early in his long career. Surely, his is a case of, "how the fallen are mighty".
It is indeed a tragedy that the man who has raised much money for cancer research and has been a source of inspiration to so many cancer sufferers, should have been exposed as a cheat.
The debate as to the ethics of using ill-gotten gains for a good cause will rage on, long after the Armstrong affair has receded into the past but one cannot help hoping that Armstrong will come to the eventual realisation, possibly a cathartic one, that true redemption and forgiveness can come only when he selflessly donates all his cycling winnings to his Livestrong foundation and begins his life afresh by earning an honest living. That is "how the fallen become mighty".
Alan Goldman is the senior analyst to Goldman Henry Capital Management, an Auckland-based fund management company.